Capuron L - Search Results

1

Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement.

Schaefer M, Capuron L, Friebe A, Diez-Quevedo C, Robaeys G, Neri S, Foster GR, Kautz A, Forton D, Pariante CM. Schaefer M, et al. Among authors: capuron l. J Hepatol. 2012 Dec;57(6):1379-90. doi: 10.1016/j.jhep.2012.07.037. Epub 2012 Aug 7. J Hepatol. 2012. PMID: 22878466

2

Preclinical animal models of mental illnesses to translate findings from the bench to the bedside: Molecular brain mechanisms and peripheral biomarkers associated to early life stress or immune challenges.

Cattane N, Vernon AC, Borsini A, Scassellati C, Endres D, Capuron L, Tamouza R, Benros ME, Leza JC, Pariante CM, Riva MA, Cattaneo A; European College of Neuropsychopharmacology (ECNP) ImmunoNeuroPsychiatry Thematic Working Group. Cattane N, et al. Among authors: capuron l. Eur Neuropsychopharmacol. 2022 May;58:55-79. doi: 10.1016/j.euroneuro.2022.02.002. Epub 2022 Feb 27. Eur Neuropsychopharmacol. 2022. PMID: 35235897 Free article. Review.

3

High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers.

Navinés R, Oriolo G, Horrillo I, Cavero M, Aouizerate B, Schaefer M, Capuron L, Meana JJ, Martin-Santos R. Navinés R, et al. Among authors: capuron l. Int J Neuropsychopharmacol. 2022 Jun 21;25(6):468-478. doi: 10.1093/ijnp/pyac016. Int J Neuropsychopharmacol. 2022. PMID: 35176771 Free PMC article.

4

Low omega-3 polyunsaturated fatty acids predict reduced response to standard antidepressants in patients with major depressive disorder.

Cussotto S, Delgado I, Oriolo G, Kemper J, Begarie D, Dexpert S, Sauvant J, Leboyer M, Aouizerate B, Martin-Santos R, Schaefer M, Capuron L. Cussotto S, et al. Among authors: capuron l. Depress Anxiety. 2022 May;39(5):407-418. doi: 10.1002/da.23257. Epub 2022 Mar 31. Depress Anxiety. 2022. PMID: 35357051

5

Brain-immune crosstalk in the treatment of major depressive disorder.

Branchi I, Poggini S, Capuron L, Benedetti F, Poletti S, Tamouza R, Drexhage HA, Penninx BWJH, Pariante CM; European College of Neuropsychopharmacology (ECNP) ImmunoNeuroPsychiatry Thematic Working Group and Marion Leboyer. Branchi I, et al. Among authors: capuron l. Eur Neuropsychopharmacol. 2021 Apr;45:89-107. doi: 10.1016/j.euroneuro.2020.11.016. Epub 2020 Dec 29. Eur Neuropsychopharmacol. 2021. PMID: 33386229

6

Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C.

Raison CL, Broadwell SD, Borisov AS, Manatunga AK, Capuron L, Woolwine BJ, Jacobson IM, Nemeroff CB, Miller AH. Raison CL, et al. Among authors: capuron l. Brain Behav Immun. 2005 Jan;19(1):23-7. doi: 10.1016/j.bbi.2004.05.001. Brain Behav Immun. 2005. PMID: 15581735

7

IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C.

Majer M, Welberg LA, Capuron L, Pagnoni G, Raison CL, Miller AH. Majer M, et al. Among authors: capuron l. Brain Behav Immun. 2008 Aug;22(6):870-80. doi: 10.1016/j.bbi.2007.12.009. Epub 2008 Feb 6. Brain Behav Immun. 2008. PMID: 18258414 Free PMC article.

8

Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction.

Raison CL, Borisov AS, Broadwell SD, Capuron L, Woolwine BJ, Jacobson IM, Nemeroff CB, Miller AH. Raison CL, et al. Among authors: capuron l. J Clin Psychiatry. 2005 Jan;66(1):41-8. doi: 10.4088/jcp.v66n0106. J Clin Psychiatry. 2005. PMID: 15669887 Free PMC article.

9

Anterior cingulate activation and error processing during interferon-alpha treatment.

Capuron L, Pagnoni G, Demetrashvili M, Woolwine BJ, Nemeroff CB, Berns GS, Miller AH. Capuron L, et al. Biol Psychiatry. 2005 Aug 1;58(3):190-6. doi: 10.1016/j.biopsych.2005.03.033. Biol Psychiatry. 2005. PMID: 16084839 Free PMC article. Clinical Trial.

10

Neuropsychiatric adverse effects of interferon-alpha: recognition and management.

Raison CL, Demetrashvili M, Capuron L, Miller AH. Raison CL, et al. Among authors: capuron l. CNS Drugs. 2005;19(2):105-23. doi: 10.2165/00023210-200519020-00002. CNS Drugs. 2005. PMID: 15697325 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters